Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Moss

Showing results (921-930 of 1,109) with videos related to

Pageof 111
Sort By:
Journal of Clinical Laboratory Analysis|January 1, 1996
Nasal mucosal cells in human immunodeficiency virus type 1-seropositive patients with sinusitisR B Moss, T A Scott, M Goldrich, et al.
American Journal of Respiratory and Critical Care Medicine|December 21, 2010
Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung functionFrank J Accurso, Richard B Moss, Robert W Wilmott, et al.
Princess Takamatsu Symposia|January 1, 1995
Prospects for prophylactic and therapeutic hepatitis C virus vaccinesM Houghton, Q L Choo, G Kuo, et al.
Molecular Biology of the Cell|April 4, 1998
Targeting of a germ cell-specific type 1 hexokinase lacking a porin-binding domain to the mitochondria as well as to the head and fibrous sheath of murine spermatozoaA J Travis, J A Foster, N A Rosenbaum, et al.
Vaccine|June 2, 1998
Safety and immunogenicity of REMUNE in HIV-infected Thai subjectsA Limsuwan, V Churdboonchart, R B Moss, et al.
Vaccine|February 1, 2003
HIV-specific immunity during structured antiviral drug treatment interruptionRonald B Moss, Carolyn Brandt, Wieslawa K Giermakowska, et al.
Molecular Reproduction and Development|January 1, 1996
Properties and localization of a tyrosine phosphorylated form of hexokinase in mouse spermP E Visconti, P Olds-Clarke, S B Moss, et al.
International Journal of Clinical Practice|March 29, 2014
Prison prescribing practice: practitioners' perspectives on why prison is differentA Bartlett, N Dholakia, R England, et al.
Clinical and Experimental Pharmacology & Physiology|May 29, 2008
Dengue fever activates the L-arginine-nitric oxide pathway: an explanation for reduced aggregation of human plateletsAntonio C Mendes-Ribeiro, Monique B Moss, Mariana As Siqueira, et al.
Scientific Reports|November 4, 2018
Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adultsJeeyeon Kim, Miesha Farahmand, Colleen Dunn, et al.
Pageof 111

Showing results (921-930 of 1,109) with videos related to

Sort By:
Pageof 111
Journal of Clinical Laboratory Analysis|January 1, 1996
Nasal mucosal cells in human immunodeficiency virus type 1-seropositive patients with sinusitisR B Moss, T A Scott, M Goldrich, et al.
American Journal of Respiratory and Critical Care Medicine|December 21, 2010
Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung functionFrank J Accurso, Richard B Moss, Robert W Wilmott, et al.
Princess Takamatsu Symposia|January 1, 1995
Prospects for prophylactic and therapeutic hepatitis C virus vaccinesM Houghton, Q L Choo, G Kuo, et al.
Molecular Biology of the Cell|April 4, 1998
Targeting of a germ cell-specific type 1 hexokinase lacking a porin-binding domain to the mitochondria as well as to the head and fibrous sheath of murine spermatozoaA J Travis, J A Foster, N A Rosenbaum, et al.
Vaccine|June 2, 1998
Safety and immunogenicity of REMUNE in HIV-infected Thai subjectsA Limsuwan, V Churdboonchart, R B Moss, et al.
Vaccine|February 1, 2003
HIV-specific immunity during structured antiviral drug treatment interruptionRonald B Moss, Carolyn Brandt, Wieslawa K Giermakowska, et al.
Molecular Reproduction and Development|January 1, 1996
Properties and localization of a tyrosine phosphorylated form of hexokinase in mouse spermP E Visconti, P Olds-Clarke, S B Moss, et al.
International Journal of Clinical Practice|March 29, 2014
Prison prescribing practice: practitioners' perspectives on why prison is differentA Bartlett, N Dholakia, R England, et al.
Clinical and Experimental Pharmacology & Physiology|May 29, 2008
Dengue fever activates the L-arginine-nitric oxide pathway: an explanation for reduced aggregation of human plateletsAntonio C Mendes-Ribeiro, Monique B Moss, Mariana As Siqueira, et al.
Scientific Reports|November 4, 2018
Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adultsJeeyeon Kim, Miesha Farahmand, Colleen Dunn, et al.
Pageof 111